Jim Bachman is a Principal at BioGenerator, focusing on enhancing portfolio companies and on new investments. Jim previously served as the President and Chief Operating Officer of BioGenerator portfolio company SynerZ Medical, where he led the company to successful exit by acquisition in 2016. Prior to SynerZ Medical, Jim was employed by Barclays Capital (formerly known as Lehman Brothers) in the healthcare group of the investment banking division where he executed mergers and acquisitions, debt and equity financing transactions. Prior to Barclays Capital he was employed in the same capacity at Piper Jaffray. Prior to Piper Jaffray, he was employed by Deloitte Financial Advisory Services, AT&T and Accenture (formerly known as Andersen Consulting). Jim received a B.A. in Biology from Saint Louis University and an M.B.A. from the Olin School of Business at Washington University in St. Louis.